Addressing the step-down process in controlled asthma

[...]the authors used a comprehensive 2-year data set within the database from the past decade and used validated definitions of asthma risk and impairment in the assessment for step change and clinical outcomes.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2016-05, Vol.137 (5), p.1380-1381
Main Author: Abramson, Stuart L., MD, PhD, AE-C
Format: Article
Language:English
Subjects:
Allergy and Immunology
Asthma
Clinical outcomes
Cost control
cost-effectiveness
patient safety
step-down
Studies
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c423t-93c1de1c01a2941467d0c9f1899af3a21536cf4308a09693a3ae2337b94c4a5c3
container_end_page 1381
container_issue 5
container_start_page 1380
container_title Journal of allergy and clinical immunology
container_volume 137
creator Abramson, Stuart L., MD, PhD, AE-C
description [...]the authors used a comprehensive 2-year data set within the database from the past decade and used validated definitions of asthma risk and impairment in the assessment for step change and clinical outcomes.
doi_str_mv 10.1016/j.jaci.2016.03.005
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1790965000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674916004292</els_id><sourcerecordid>4050649131</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-93c1de1c01a2941467d0c9f1899af3a21536cf4308a09693a3ae2337b94c4a5c3</originalsourceid><addsrcrecordid>eNqNkk9r3DAQxUVoSDZpv0APxdBLL3ZGfyxbUAohNG0hkEOSs1BG40au195K3oZ8-8jZtIUcSk-S0O895j2GsbccKg5cn_RV7zBUIt8rkBVAvcdWHExT6lbUr9gKwPBSN8ocsqOUeshv2ZoDdigaXtcg1YrVp95HSimM34v5joo006b00_1YbOKE-aMIY4HTOMdpGMgXLs13a_ea7XduSPTm-TxmN-efr8--lheXX76dnV6UqIScSyORe-II3AmjuNKNBzQdb41xnXSC11JjpyS0Dow20klHQsrm1ihUrkZ5zD7sfPMwP7eUZrsOCWkY3EjTNlnemCysc7D_QNum0XkMndH3L9B-2sYxB3miWqG4VpkSOwrjlFKkzm5iWLv4YDnYpX_b26V_u_RvQdrcfxa9e7be3q7J_5H8LjwDH3cA5dp-BYo2YaARyYdIOFs_hX_7f3ohxyGMAd3wgx4o_c1hk7Bgr5YNWBaAawAljJCPY2-oHQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1787824164</pqid></control><display><type>article</type><title>Addressing the step-down process in controlled asthma</title><source>ScienceDirect Freedom Collection</source><creator>Abramson, Stuart L., MD, PhD, AE-C</creator><creatorcontrib>Abramson, Stuart L., MD, PhD, AE-C</creatorcontrib><description>[...]the authors used a comprehensive 2-year data set within the database from the past decade and used validated definitions of asthma risk and impairment in the assessment for step change and clinical outcomes.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2016.03.005</identifier><identifier>PMID: 27155034</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Allergy and Immunology ; Asthma ; Clinical outcomes ; Cost control ; cost-effectiveness ; patient safety ; step-down ; Studies</subject><ispartof>Journal of allergy and clinical immunology, 2016-05, Vol.137 (5), p.1380-1381</ispartof><rights>American Academy of Allergy, Asthma &amp; Immunology</rights><rights>2016 American Academy of Allergy, Asthma &amp; Immunology</rights><rights>Copyright Elsevier Limited May 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c423t-93c1de1c01a2941467d0c9f1899af3a21536cf4308a09693a3ae2337b94c4a5c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27155034$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abramson, Stuart L., MD, PhD, AE-C</creatorcontrib><title>Addressing the step-down process in controlled asthma</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>[...]the authors used a comprehensive 2-year data set within the database from the past decade and used validated definitions of asthma risk and impairment in the assessment for step change and clinical outcomes.</description><subject>Allergy and Immunology</subject><subject>Asthma</subject><subject>Clinical outcomes</subject><subject>Cost control</subject><subject>cost-effectiveness</subject><subject>patient safety</subject><subject>step-down</subject><subject>Studies</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkk9r3DAQxUVoSDZpv0APxdBLL3ZGfyxbUAohNG0hkEOSs1BG40au195K3oZ8-8jZtIUcSk-S0O895j2GsbccKg5cn_RV7zBUIt8rkBVAvcdWHExT6lbUr9gKwPBSN8ocsqOUeshv2ZoDdigaXtcg1YrVp95HSimM34v5joo006b00_1YbOKE-aMIY4HTOMdpGMgXLs13a_ea7XduSPTm-TxmN-efr8--lheXX76dnV6UqIScSyORe-II3AmjuNKNBzQdb41xnXSC11JjpyS0Dow20klHQsrm1ihUrkZ5zD7sfPMwP7eUZrsOCWkY3EjTNlnemCysc7D_QNum0XkMndH3L9B-2sYxB3miWqG4VpkSOwrjlFKkzm5iWLv4YDnYpX_b26V_u_RvQdrcfxa9e7be3q7J_5H8LjwDH3cA5dp-BYo2YaARyYdIOFs_hX_7f3ohxyGMAd3wgx4o_c1hk7Bgr5YNWBaAawAljJCPY2-oHQ</recordid><startdate>20160501</startdate><enddate>20160501</enddate><creator>Abramson, Stuart L., MD, PhD, AE-C</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20160501</creationdate><title>Addressing the step-down process in controlled asthma</title><author>Abramson, Stuart L., MD, PhD, AE-C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-93c1de1c01a2941467d0c9f1899af3a21536cf4308a09693a3ae2337b94c4a5c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Allergy and Immunology</topic><topic>Asthma</topic><topic>Clinical outcomes</topic><topic>Cost control</topic><topic>cost-effectiveness</topic><topic>patient safety</topic><topic>step-down</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abramson, Stuart L., MD, PhD, AE-C</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abramson, Stuart L., MD, PhD, AE-C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Addressing the step-down process in controlled asthma</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2016-05-01</date><risdate>2016</risdate><volume>137</volume><issue>5</issue><spage>1380</spage><epage>1381</epage><pages>1380-1381</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>[...]the authors used a comprehensive 2-year data set within the database from the past decade and used validated definitions of asthma risk and impairment in the assessment for step change and clinical outcomes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27155034</pmid><doi>10.1016/j.jaci.2016.03.005</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2016-05, Vol.137 (5), p.1380-1381
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_miscellaneous_1790965000
source ScienceDirect Freedom Collection
subjects Allergy and Immunology
Asthma
Clinical outcomes
Cost control
cost-effectiveness
patient safety
step-down
Studies
title Addressing the step-down process in controlled asthma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T01%3A51%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Addressing%20the%20step-down%20process%20in%20controlled%20asthma&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Abramson,%20Stuart%20L.,%20MD,%20PhD,%20AE-C&rft.date=2016-05-01&rft.volume=137&rft.issue=5&rft.spage=1380&rft.epage=1381&rft.pages=1380-1381&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2016.03.005&rft_dat=%3Cproquest_cross%3E4050649131%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c423t-93c1de1c01a2941467d0c9f1899af3a21536cf4308a09693a3ae2337b94c4a5c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1787824164&rft_id=info:pmid/27155034&rfr_iscdi=true